Triglav Investments, D.o.o. »

BioMarin Pharmaceutical shares owned by Triglav Investments, D.o.o.

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Triglav Investments, D.o.o. from 13F filings

Historical chart of Triglav Investments, D.o.o. investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Triglav Investments, D.o.o. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Triglav Investments, D.o.o.

Quarter filed Position value Share count Share price at filing
2025-09-30 $894k 17k 54.16
2025-06-30 $907k 17k 54.97

More positions owned by Triglav Investments, D.o.o.

Nvidia Corporation Common (NVDA)
Microsoft Corporation Common (MSFT)
Apple Common (AAPL)
Amazon.com Common (AMZN)
Meta Platforms Common (META)
Jpmorgan Chase & Co. Common (JPM)
Broadcom Common (AVGO)
Alphabet Common (GOOGL)
Eli Lilly And Company Common (LLY)
Goldman Sachs Group Common (GS)
Netflix Common (NFLX)
Tesla Motors Common (TSLA)
Oracle Corporation Common (ORCL)
Palantir Technologies Common (PLTR)
Visa Common (V)

View all positions for Triglav Investments, D.o.o.

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Millennium Management
Capital Research Global Investors
UBS Group
Goldman Sachs Group
Dimensional Fund Advisors
Renaissance Technologies
Northern Trust

View all funds holding BioMarin Pharmaceutical